News Chart ABL Bio Inc.

Equities

A298380

KR7298380007

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-07-10 pm EDT			5-day change	1st Jan Change
26,550 ^KRW	-3.80%		-10.61%	+7.93%

Jun. 10	ABL Bio, BMS Collaborate on Gastric Cancer Treatment Trial	MT
Mar. 25	Biocytogen Pharmaceuticals Co., Ltd. Enters Collaboration with ABL Bio Inc. to Develop New Bispecific Antibody-Drug Conjugates	CI

2f9b177a1e5d1b3a4d6916a.1tMkBt5CYChi3zlN48zHxWTHSbb0iCXCMFJlg93O9Gw.56JFaot0TUkF7E8EqqKi9heiPeyD4hWNAjxU6462nxac_nVlpnERECqrYA~2293d6f695fa8419092a09a311742ec2